---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-031930"
form_type: "8-K"
ticker: "ERNA"
cik: "0000748592"
company_name: "Ernexa Therapeutics Inc."
filed_at: "2026-07-02T20:40:47+00:00"
generated_at: "2026-07-02T20:42:12.747444+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Ernexa Therapeutics posts updated investor presentation; no specific details provided

## Summary
- Updated presentation posted on July 2, 2026, replacing the February 26, 2026 version.
- Presentation available on company website from July 3, 2026.
- No financial or operational updates disclosed in the filing.

## SEC filing metadata
- accession: 0001493152-26-031930
- form_type: 8-K
- ticker: ERNA
- cik: 0000748592
- company_name: Ernexa Therapeutics Inc.
- filed_at: 2026-07-02T20:40:47+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/748592/000149315226031930/0001493152-26-031930-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/748592/000149315226031930/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-031930
- JSON: https://secwatch.observer/filing/0001493152-26-031930.json
- Plain text: https://secwatch.observer/filing/0001493152-26-031930.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.